Quarterly report pursuant to Section 13 or 15(d)

Revenue Disclosures - Changes in Contract Assets and Contract Liabilities (Details)

v3.23.3
Revenue Disclosures - Changes in Contract Assets and Contract Liabilities (Details)
9 Months Ended
Sep. 30, 2023
USD ($)
Deferred Revenue from company clinics  
Balance, beginning $ 7,471,549
Revenue recognized that was included in the contract liability at the beginning of the year (5,959,308)
nine months ended September 30, 2023 5,026,472
Balance, ending 6,538,713
Deferred Revenue short and long-term  
Balance, beginning 16,629,735
Revenue recognized that was included in the contract liability at the beginning of the year (2,042,823)
nine months ended September 30, 2023 1,906,196
Balance, ending 16,493,108
Deferred Franchise and Development Costs short and long-term  
Balance, beginning 6,761,738
Cost of revenue recognized that was included in the contract asset at the beginning of the year (863,619)
nine months ended September 30, 2022 566,339
Balance, ending $ 6,464,458